IBIO vs IMMX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 13, 2026

IBIO

43.1
AI Score
VS
IBIO Wins

IMMX

39.4
AI Score

Investment Advisor Scores

IBIO

43score
Recommendation
HOLD

IMMX

39score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric IBIO IMMX Winner
Revenue 400,000 20.00M IMMX
Net Income -18.38M -21.64M IBIO
Net Margin -4594.3% -108.2% IMMX
Operating Income -18.60M -23.26M IBIO
ROE -123.5% -9.5% IMMX
ROA -79.3% -9.1% IMMX
Total Assets 23.18M 239.11M IMMX
Cash 8.58M 225.49M IMMX
Current Ratio 1.59 25.13 IMMX
Free Cash Flow -15.32M -21.62M IBIO

Relative Price Performance (Last 90 Days)

IBIO 1M: -1.4% · 3M: -23.4% IMMX 1M: +56.9% · 3M: +52.3%

Current Technical Phase

IBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 45.7 · Price: $1.41

IMMX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (8.0% over 20 days), RSI 71

RSI (14): 71.1 · Price: $13.37

Fundamentals Snapshot

Metric IBIO IMMX
Market Cap
Forward P/E -4.6 -15.1
Trailing P/E
Revenue (TTM)
Revenue Growth 0.1% 0.0%
Gross Margin 1.0%
Operating Margin -96.5% 0.0%
EPS -0.55 -0.88
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, IBIO is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.